4.4 Review

Vitamin C: A new auxiliary treatment of epilepsy?

Journal

PHARMACOLOGICAL REPORTS
Volume 66, Issue 4, Pages 529-533

Publisher

POLISH ACAD SCIENCES INST PHARMACOLOGY
DOI: 10.1016/j.pharep.2014.02.016

Keywords

Ascorbic acid; Epilepsy; Seizures; Neurodegeneration

Funding

  1. Medical University of Lublin [DS. 475/13]

Ask authors/readers for more resources

Although many approaches to the therapy of epilepsy exist, most of antiepileptic drugs, beside certain and unquestioned benefits, have convinced disadvantages. That is the reason for looking for new methods of treatment. Ascorbic acid, as an antioxidant and electron donor accumulated in central nervous system, seems to take part in diminishing reactions of oxidative stress in brain and cooperate with other antioxidants like alpha-tocoferol. Vitamin C, easily transported through the blood-brain barrier, is proved to reduce injury in the hippocampus during seizures. Depending on type of seizures, it has mostly inhibitory activity and even decreases mortality. Moreover, vitamin C acts as a neuroprotective factor by consolidating cell membranes and decreasing lipid peroxidation. A possible adjunctive role of vitamin C in epileptic patients needs to be considered. (C) 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. Z o.o. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pharmacology & Pharmacy

Assessment of drug-drug interactions between moxonidine and antiepileptic drugs in the maximal electroshock seizure test in mice

Krzysztof Lukawski, Stanislaw Jerzy Czuczwar

Summary: This study investigated the effects of moxonidine on the anticonvulsant efficacy of various AEDs in an animal model, showing that it could potentiate the protective effect of valproate, possibly through pharmacodynamic interactions, without causing adverse effects when combined with AEDs. Further research is needed to elucidate the potential mechanisms involved in the enhancement of valproate's anticonvulsant action by moxonidine.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2022)

Review Pharmacology & Pharmacy

Emerging therapeutic targets for epilepsy: preclinical insights

Krzysztof Lukawski, Stanislaw J. Czuczwar

Summary: This article discusses novel drug targets for the management of drug-resistant seizures, including brain multidrug efflux transporters and inflammatory pathways. Strategies for reducing blood brain barrier dysfunction and enhancing anti-oxidative defense are also explored.

EXPERT OPINION ON THERAPEUTIC TARGETS (2022)

Review Biochemistry & Molecular Biology

Post-Ischemic Neurodegeneration of the Hippocampus Resembling Alzheimer's Disease Proteinopathy

Ryszard Pluta, Slawomir Januszewski, Stanislaw J. Czuczwar

Summary: This review summarizes the protein and gene changes associated with Alzheimer's disease and their role in post-ischemic hippocampal neurodegeneration. Dysregulation of the genes for the amyloid protein precursor metabolism and tau protein, similar to Alzheimer's disease, is found in the hippocampus. Amyloid and tau protein, derived from brain tissue and blood due to increased permeability of the blood-brain barrier after ischemia, play a key role in post-ischemic neurodegeneration and the development of dementia. Understanding these neurodegenerative mechanisms is crucial for therapeutic development.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Pharmacology & Pharmacy

Effect of caffeine on the anticonvulsant action of pregabalin against electroconvulsions in mice

Roman Chwedorowicz, Krzysztof Lukawski, Grzegorz Raszewski, Stanislaw J. Czuczwar

Summary: The study found that caffeine reduces the anticonvulsant action of pregabalin against seizures without affecting their brain concentration. Additionally, caffeine protects against motor coordination impairment induced by pregabalin.

PHARMACOLOGICAL REPORTS (2022)

Article Nutrition & Dietetics

Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy: Possible Therapeutic Role of Curcumin

Ryszard Pluta, Wanda Furmaga-Jablonska, Slawomir Januszewski, Stanislaw J. Czuczwar

Summary: Curcumin, a natural polyphenolic compound, has pleiotropic biological properties and can regulate changes in the brain after ischemia and neurodegenerative diseases. It can prevent the aggregation and insolubility of aging-related proteins, and reduce neurotoxicity. Animal models of cerebral ischemia have demonstrated that curcumin can reduce various pathological changes and improve neurological and behavioral deficits.

NUTRIENTS (2022)

Review Biochemistry & Molecular Biology

Cross-Talk between Amyloid, Tau Protein and Free Radicals in Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy

Ryszard Pluta, Jacek Kis, Slawomir Januszewski, Miroslaw Jablonski, Stanislaw J. Czuczwar

Summary: Recent research into free radicals oxidative stress has made significant progress, especially in the context of post-ischemic recirculation brain injury. Oxidative stress in post-ischemic tissues damages the integrity of the genome, leading to DNA damage, neuronal, glial and vascular cell death, and impaired neurological functioning after brain ischemia. DNA damage and repair are now understood to play a crucial role in post-stroke white and gray matter remodeling, and the restoration of the blood-brain barrier. This review explores a newly discovered mechanism involving genomic and proteomic development that takes brain ischemia to a new level of post-ischemic neuropathological mechanisms, including the presence of amyloid plaques and the development of neurofibrillary tangles, which further contribute to oxidative stress. Additionally, the modified amyloid and tau protein, along with the generated oxidative stress, are hypothesized to be key elements in the vicious circle that contributes to the development of post-ischemic neurodegeneration in a type of Alzheimer's disease proteinopathy.

ANTIOXIDANTS (2022)

Article Environmental Sciences

Neurotoxic effects of combined exposure to caffeine and pyrethroids in mice

Krzysztof Lukawski, Grzegorz Raszewski, Stanislaw Jerzy Czuczwar

Summary: This study demonstrates that co-exposure to caffeine may increase the neurotoxicity of tefluthrin. The interaction between tefluthrin and caffeine with the cholinergic system, resulting in a decrease in AChE activity in the brain, is not responsible for the observed effect in the rotarod test.

ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE (2022)

Review Biochemistry & Molecular Biology

Molecular Hydrogen Neuroprotection in Post-Ischemic Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy: Underlying Mechanisms and Potential for Clinical Implementation-Fantasy or Reality?

Ryszard Pluta, Slawomir Januszewski, Stanislaw J. Czuczwar

Summary: This article highlights the neuroprotective effects of molecular hydrogen following ischemic brain injury, including its potential for improving cognitive and neurological deficits and preventing neurodegenerative changes. The study suggests that molecular hydrogen may be a promising therapeutic agent in the treatment of neurodegenerative diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Geriatrics & Gerontology

Crosstalk between the aging intestinal microflora and the brain in ischemic stroke

Ryszard Pluta, Miroslaw Jablonski, Slawomir Januszewski, Stanislaw J. Czuczwar

Summary: This article examines the impact of aging on the microbiota-gut-brain axis, emphasizing that all elements are subject to age-related changes. The interaction between microbiota, microglia, and neurons in the brain after ischemic stroke in elderly individuals is also discussed, along with clinical studies on the role of the aged microbiota-gut-brain axis in the development of stroke risk factors and changes in the post-stroke microflora.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Review Pharmacology & Pharmacy

Comorbid epilepsy and depression-pharmacokinetic and pharmacodynamic drug interactions

Barbara Miziak, Stanislaw J. Czuczwar, Ryszard Pluta

Summary: Patients with epilepsy may require antidepressant treatment due to the high prevalence of depression in this population. There may be pharmacodynamic and pharmacokinetic interactions between antiepileptic and antidepressant drugs. Animal data suggest that chronic administration of antidepressants can either enhance or reduce the anticonvulsant activity of certain antiepileptic drugs.

FRONTIERS IN PHARMACOLOGY (2022)

Review Pharmacology & Pharmacy

Approaches for the discovery of drugs that target K Na 1.1 channels in KCNT1-associated epilepsy

Barbara Miziak, Stanislaw J. Czuczwar

Summary: The article reviews several methods for studying KNa 1.1 channels and discusses available drugs for the management of KCNT1 epilepsies. It also suggests a combined approach with in silico methods and animal models to create personalized treatment for patients with KCNT1 gene mutations.

EXPERT OPINION ON DRUG DISCOVERY (2022)

Review Biochemistry & Molecular Biology

The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer's Disease: New Potential Treatment Target

Marta Rusek, Joanna Smith, Kamel El-Khatib, Kennedy Aikins, Stanislaw J. Czuczwar, Ryszard Pluta

Summary: Alzheimer's disease is not only characterized by the accumulation of amyloid plaques and neurofibrillary tangles, but also involves neuroinflammation. The interplay between the nervous and immune systems might be crucial in preventing or delaying the progression of Alzheimer's disease. The JAK/STAT signaling pathway, influenced by the overactivation of microglia and astrocytes, plays an important role in determining the fate of gliogenic cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Clinical Neurology

Attenuation of initial pilocarpine-induced electrographic seizures by methionine sulfoximine pretreatment tightly correlates with the reduction of extracellular taurine in the hippocampus

Marek Pawlik, Anna Maria Czarnecka, Marcin Kolodziej, Katarzyna Skowronska, Michal Wegrzynowicz, Martyna Podgajna, Stanislaw Jerzy Czuczwar, Jan Albrecht

Summary: This study found that pretreatment with a glutamine synthetase inhibitor, methionine sulfoximine (MSO), can mitigate the intensity of seizures during the initial phase. The protective effect of MSO is achieved by preventing an increase in cell volume.

EPILEPSIA (2023)

Review Biochemistry & Molecular Biology

Second Generation of Antiepileptic Drugs and Oxidative Stress

Kamil Kosmider, Maciej Kamieniak, Stanislaw J. Czuczwar, Barbara Miziak

Summary: Epilepsy is a chronic disease that causes recurrent seizures due to excessive oxidants formed during epileptic seizures. This review examines the relationship between newer antiepileptic drugs and oxidative stress. It suggests that drugs enhancing GABA-ergic transmission or other antiepileptics can reduce neuronal oxidation markers, but high doses of GABA-enhancing drugs may increase oxidative stress. Additionally, diazepam has a neuroprotective effect in a U-shaped dose-dependent manner.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

Post-Ischemic Permeability of the Blood-Brain Barrier to Amyloid and Platelets as a Factor in the Maturation of Alzheimer's Disease-Type Brain Neurodegeneration

Ryszard Pluta, Barbara Miziak, Stanislaw J. Czuczwar

Summary: The aim of this review is to present evidence of the impact of ischemic changes in the blood-brain barrier on the maturation of post-ischemic brain neurodegeneration with features of Alzheimer's disease. Understanding the processes involved in the permeability of the post-ischemic blood-brain barrier during recirculation will provide clinically relevant knowledge regarding the neuropathological changes that ultimately lead to dementia of the Alzheimer's disease type. This review distinguishes between primary and secondary neuropathological processes during and after ischemia, observing two stages that contribute to Alzheimer's disease development.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

No Data Available